End of Enrollment for the Sore Throat Trial
The enrollment was completed for a phase IV, multicenter, randomized, non-inferiority trial by reaching the study-wide goal of including 360 patients.
GCT is responsible for managing project in Russia where the patient enrolment began in August 2020.
July 29, 2021
First Patient in Idiopathic Pulmonary Fibrosis Study
The first patient has been included in this clinical trial in Russia. The study is a Phase 2, Multi-Centre, Open-Label, Single-Arm Trial Investigating the Safety, Efficacy of IP aiming to help those suffering from IPF.
Idiopathic pulmonary fibrosis is a chronic, progressive lung disease. When it occurs, scar tissue (fibrosis) is accumulated in the lungs, making it very difficult for the lungs to transport oxygen efficiently into the bloodstream.
July 13, 2021
GCT to Participate in a New Global COVID-19 Study
GCT has just been awarded a new clinical study related to SARS-CoV-2.
It is a double-blind, randomized, placebo-controlled, phase II study in hospitalized patients infected with severe acute respiratory syndrome-coronavirus-2. The Sponsor is a Swiss Biotech. For this study, 150 patients will be enrolled at the Russian sites.
July 28, 2021
First Patient In Endometriosis Clinical Trial in Ukraine
Global Clinical Trials announces the first successful screening in the endometriosis study.
It is a Phase III double-blind, three-arm superiority study in 200+ subjects that is being conducted in Ukraine. The study aims to assess the safety and efficacy of the Investigational Product (IP) for treatment of endometriosis in women of reproductive age.
July 6, 2021
GCT Celebrates 20 Years of Successfully Managing Clinical Trials
Global Clinical Trials, LLC (“GCT”) is a premier contract research organization providing clinical services in the U.S., Europe, and Asia.
The company is delighted to announce the celebration of 20 years helping small and large pharma, biotech and medical device companies run their clinical studies.
In the following months, GCT will be publishing media content, including the stories of GCT employees and empirical lessons that contributed most to the growth of the company and its service offerings.
June 23, 2021
GCT to provide regulatory support for Novel Wet Age-related Macular Degeneration Treatment
GCT has been awarded a new regulatory project — an ophthalmological study for a Korean biotechnology company.
A novel wet age-related macular degeneration (Wet-AMD) treatment is to be investigated. The sponsor has requested GCT to provide the regulatory support services for the IND application prior to the clinical trials.
GCT’s regulatory group will perform the necessary activities to file the IND and proceed with required clinical trials in US and globally.
June 8, 2021
Approval for Endometriosis study in Ukraine obtained
Global Clinical Trials has been recently awarded to run a new project in Women’s Health. The goal of the study is to assess the efficacy and safety of the Investigational Product (IP) for the treatment of endometriosis in women of reproductive age.
On March 23rd, 2021, the State Expert Centre of MOH of Ukraine has issued approval to begin the enrollment.
April 6, 2021
Meet our clients
All trademarks, brand names and logotypes are intellectual property of their respective owners.